Literature DB >> 18055987

Thrombin-generating capacity in patients with von Willebrand's disease.

Lucia Rugeri1, Suzette Beguin, Coenraad Hemker, Jean-Claude Bordet, Raphael Fleury, Brigitte Chatard, Claude Negrier, Yesim Dargaud.   

Abstract

BACKGROUND AND OBJECTIVES: on Willebrand's disease (VWD) is the most common hereditary bleeding disorder. Its severity can be classified on the basis of von Willebrand factor (VWF) and factor VIII (FVIII) plasma levels and according to the clinical relevance of bleeding episodes. However, patients with very low VWF activity may exhibit a mild bleeding tendency. The basis for this heterogeneous clinical expression of the deficit is still poorly understood. We investigated the relationship between thrombin generation and levels of factor VIII, VWF and clinical bleeding tendency. DESIGN AND METHODS: Thrombin generation was measured in platelet-rich (PRP) and platelet-poor plasma (PPP) from 53 patients with VWD.
RESULTS: We observed a statistically significant higher risk of bleeding in patients with a low thrombin peak in PRP (OR=14.5; 95% CI=5-41.3). Similar results were found in PPP (OR=8.71; 95% CI=3.4-22.3). Two parameters of the thrombin generation curve, peak height and thrombin generation speed (slope), correlated significantly with VWF:RCo and FVIII levels both in PPP and in PRP. Regression analysis showed that thrombin generation was mainly dependent on plasma FVIII activity. INTERPRETATION AND
CONCLUSIONS: Our results suggest that the thrombin generation test, in combination with routine FVIII and VWF measurements, could be of interest in the assessment of the individual bleeding risk in patients with VWD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055987     DOI: 10.3324/haematol.11460

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  14 in total

Review 1.  Thrombin generation and bleeding in cardiac surgery: a clinical narrative review.

Authors:  John Fitzgerald; Robert McMonnies; Aidan Sharkey; Peter L Gross; Keyvan Karkouti
Journal:  Can J Anaesth       Date:  2020-03-04       Impact factor: 5.063

2.  Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.

Authors:  N C Olson; S Butenas; L A Lange; E M Lange; M Cushman; N S Jenny; J Walston; J C Souto; J M Soria; G Chauhan; S Debette; W T Longstreth; S Seshadri; A P Reiner; R P Tracy
Journal:  J Thromb Haemost       Date:  2015-09-14       Impact factor: 5.824

3.  Effect of Hemodilution In Vitro with Hydroxyethyl Starch on Hemostasis.

Authors:  Shanliang Jin; Guifang Yu; Ruijiao Hou; Boxiong Shen; Hong Jiang
Journal:  Med Sci Monit       Date:  2017-05-08

4.  Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.

Authors:  Igor Govorov; Katarina Bremme; Tomas L Lindahl; Margareta Holmström; Eduard Komlichenko; Roza Chaireti; Miriam Mints
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

5.  Blood inflammatory and endothelial markers in women with von Willebrand disease.

Authors:  Igor Govorov; Katarina Bremme; Anders Larsson; Margareta Holmström; Eduard Komlichenko; Roza Chaireti; Miriam Mints
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

6.  Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.

Authors:  Stefanie Hofer; Cihan Ay; Judit Rejtö; Alisa S Wolberg; Helmuth Haslacher; Silvia Koder; Ingrid Pabinger; Johanna Gebhart
Journal:  J Thromb Haemost       Date:  2019-07-15       Impact factor: 5.824

7.  Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study.

Authors:  Taleen A MacArthur; Julie Goswami; Laurie Moon Tasson; Alexander Tischer; Kent R Bailey; Grant M Spears; Jing-Fei Dong; Matthew Auton; Rosemary Kozar; Myung S Park
Journal:  Trauma Surg Acute Care Open       Date:  2021-04-05

8.  Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

Authors:  C P D M de Breet; S Zwaveling; M J A Vries; R G van Oerle; Y M C Henskens; A W J Van't Hof; P E J van der Meijden; L Veenstra; H Ten Cate; R H Olie
Journal:  Front Cardiovasc Med       Date:  2021-06-10

9.  Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.

Authors:  Ivan D Tarandovskiy; Elena O Artemenko; Mikhail A Panteleev; Elena I Sinauridze; Fazoil I Ataullakhanov
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 10.  Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets.

Authors:  Marina Panova-Noeva; Paola E J van der Meijden; Hugo Ten Cate
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.